ARTERRA BIOSCIENCE (ARBS.MI)

EUR 2.16

(1.89%)

Gross Profit Summary of ARTERRA BIOSCIENCE

ARTERRA BIOSCIENCE's latest annual gross profit in 2023 was -157.83 Thousand EUR , down -138.57% from previous year.
ARTERRA BIOSCIENCE's latest quarterly gross profit in 2024 Q2 was 1.4 Million EUR , down 0.0% from previous quarter.
ARTERRA BIOSCIENCE reported a annual gross profit of 492.76 Thousand EUR in annual gross profit 2022, down -26.8% from previous year.
ARTERRA BIOSCIENCE reported a annual gross profit of 673.13 Thousand EUR in annual gross profit 2021, up 2083.53% from previous year.
ARTERRA BIOSCIENCE reported a quarterly gross profit of 619.14 Thousand EUR for 2023 Q4, down 0.0% from previous quarter.
ARTERRA BIOSCIENCE reported a quarterly gross profit of -190.07 Thousand EUR for 2023 FY, down -138.57% from previous quarter.

Annual Gross Profit Chart of ARTERRA BIOSCIENCE (2023 - 2017)

Historical Annual Gross Profit of ARTERRA BIOSCIENCE (2023 - 2017)

Year	Gross Profit	Gross Profit Growth
2023	-157.83 Thousand EUR	-138.57%
2022	492.76 Thousand EUR	-26.8%
2021	673.13 Thousand EUR	2083.53%
2020	30.82 Thousand EUR	-90.51%
2019	324.93 Thousand EUR	-54.19%
2018	709.32 Thousand EUR	28.02%
2017	554.08 Thousand EUR	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	1.4 Million EUR	0.0%
2023 Q4	619.14 Thousand EUR	0.0%
2023 FY	-190.07 Thousand EUR	-138.57%
2023 Q2	-489.97 Thousand EUR	0.0%
2022 FY	492.76 Thousand EUR	-26.8%
2022 Q2	624.56 Thousand EUR	0.0%
2022 Q4	-131.8 Thousand EUR	0.0%
2021 Q2	-6206.00 EUR	0.0%
2021 FY	673.13 Thousand EUR	2083.53%
2021 Q4	679.34 Thousand EUR	0.0%
2020 Q4	4014.00 EUR	0.0%
2020 Q2	26.81 Thousand EUR	0.0%
2020 FY	30.82 Thousand EUR	-90.51%
2019 Q3	700.88 Thousand EUR	-32.81%
2019 FY	324.93 Thousand EUR	-54.19%
2019 Q4	-93.27 Thousand EUR	-113.31%
2019 Q2	1.04 Million EUR	0.0%
2018 Q4	521.96 Thousand EUR	0.0%
2018 FY	709.32 Thousand EUR	28.02%
2018 Q2	661.21 Thousand EUR	0.0%
2017 FY	554.08 Thousand EUR	0.0%

Peer Gross Profit Comparison of ARTERRA BIOSCIENCE

Name	Gross Profit	Gross Profit Difference
Philogen S.p.A.	5.66 Million EUR	102.784%
Ulisse Biomed S.p.A.	-2.37 Million EUR	93.358%